You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AKT1

Showing 1 - 25 of 928
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Middletown, New Jersey
  • +2 more
Jul 5, 2022

Advanced Solid Tumors Trial (WGI-0301)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 11, 2022

Seborrheic Keratosis Trial in Santa Tecla (SM-020)

Recruiting
  • Seborrheic Keratosis
  • Santa Tecla, La Libertad, El Salvador
    Zepeda Dermatologia
Aug 20, 2022

Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

Terminated
Has Results
  • Cancer
  • Solid Tumors
  • Las Vegas, Nevada
  • +5 more
Jun 14, 2022

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Canada (Laboratory Biomarker Analysis, Pharmacological

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +3 more
  • Calgary, Alberta, Canada
  • +4 more
Feb 10, 2022

Colorectal Adenomatous Polyp, Colorectal Carcinoma, Familial Adenomatous Polyposis Trial in United States (procedure, drug,

Not yet recruiting
  • Colorectal Adenomatous Polyp
  • +3 more
  • Biopsy
  • +5 more
  • Ann Arbor, Michigan
  • +4 more
Jan 3, 2023

Breast Cancer Trial in France (next-generation sequencing (NGS))

Active, not recruiting
  • Breast Cancer
  • next-generation sequencing (NGS)
  • Metz, France
  • +9 more
Aug 25, 2021

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic

Not yet recruiting
  • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Sep 13, 2022

Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Manchester, Greater Manchester, United Kingdom
  • +20 more
Aug 5, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,

Withdrawn
  • Recurrent Glioblastoma
  • +3 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 10, 2021

Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

Completed
  • Proteus Syndrome
  • MK-7075 (miransertib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2022

Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Cancer
  • London, United Kingdom
    Barts Health NHS Trust
Aug 10, 2022

Study of Proteus Syndrome and Related Congenital Disorders

Recruiting
  • Proteus Syndrome
  • PIK3CA Related Overgrowth Spectrum
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +35 more
    • Akt inhibitor MK2206
    • laboratory biomarker analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 14, 2020

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +17 more
    • Biopsy
    • +3 more
    • Augusta, Georgia
    • +4 more
    Jan 25, 2023

    Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

    Completed
    Has Results
    • Gastric Cancer
    • Los Angeles, California
    • +33 more
    Feb 18, 2022

    Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, Capivasertib, Placebo)

    Active, not recruiting
    • Locally Advanced (Inoperable) or Metastatic Breast Cancer
    • Gilbert, Arizona
    • +214 more
    Feb 1, 2023

    Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
      A. Brent Carter
    Aug 3, 2023

    Metastatic Breast Cancer Trial in Italy (Both blood and tissues collection for patients with metastatic breast cancer HER2+

    Completed
    • Metastatic Breast Cancer
    • Both blood and tissues collection for patients with metastatic breast cancer HER2+ pretreated with no more than one line of anti-HER2 therapy for advanced breast cancer.
    • Bergamo, Italy
    • +8 more
    Feb 9, 2023

    Integrated Molecular Profiling in Advanced Cancers Trial

    Active, not recruiting
    • Breast Cancer
    • +9 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Sep 26, 2022

      Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

      Recruiting
      • Proteus Syndrome
      • MK-7075 (miransertib)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Nov 19, 2022

      Gastric Cancer, Healthy Trial in Hangzhou (No intervention)

      Recruiting
      • Gastric Cancer
      • Healthy
      • No intervention
      • Hangzhou, Zhejiang, China
        Cancer Hospital of the University of Chinese Academy of Sciences
      Aug 7, 2023

      Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

      Recruiting
      • Breast Cancer
      • Bowral, New South Wales, Australia
      • +37 more
      Aug 8, 2022

      Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)

      Recruiting
      • Metastatic Breast Cancer
      • Badalona, Barcelona, Spain
      • +9 more
      Oct 24, 2022